Analysis of NR2F1 gene variant in a child with optic atrophy and global developmental delay.
10.3760/cma.j.cn511374-20221023-00710
- Author:
Yang TIAN
1
;
Jiahao CAI
;
Xufang LI
;
Lianfeng CHEN
;
Ting KANG
;
Wenxiong CHEN
Author Information
1. Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong 510623, China. gzchcwx@126.com.
- Publication Type:Journal Article
- MeSH:
Female;
Humans;
Infant;
Computational Biology;
COUP Transcription Factor I/genetics*;
Genetic Testing;
Genomics;
Genotype;
Optic Atrophy/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(10):1301-1305
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the genetic basis for a child with optic atrophy and global developmental delay.
METHODS:A child who had presented at the Guangzhou Women and Children's Medical Center in January 2022 was selected as the study subject. Clinical data were collected. Whole exome sequencing (WES) was carried out for the child. Candidate variant was validated by Sanger sequencing and bioinformatic analysis.
RESULTS:The child, a nine-month-old female, had manifested dysopia and global developmental delay. Genetic testing revealed that she has harbored a de novo c.425G>C (p.Arg142Pro) variant of the NR2F1 gene, which has been associated with Bosch-Boonstra-Schaaf syndrome. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the variant was classified as pathogenic (PS2+PM1+PM2_Supporting+PM5+PP3+PP4).
CONCLUSION:The c.425G>C (p.Arg142Pro) variant of the NR2F1 gene probably underlay the pathogenesis in this child. Above finding has enriched the genotypic and phenotypic spectrum of the NR2F1 gene.
